U.S. market Closed. Opens in 1 day 5 hours 24 minutes

ANGN | Angion Biomedica Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312013-12-312012-12-31
Revenue2.30M28.31M2.88M1.49M4.03M6.58M7.30M
Cost of RevenueN/A433.00K1.19M640.00K378.00K3.17M3.67M
Gross Profit2.30M27.88M1.69M847.00K3.65M3.41M3.62M
Operating Expenses32.74M67.19M56.96M39.44M17.99M3.81M4.04M
Selling, General & Admin14.64M18.49M17.99M9.60M5.39MN/AN/A
Research & Development18.10M48.70M38.98M29.84M12.60M196.01KN/A
Other Operating Expenses9.19M-15.27M-24.83M-583.00KN/A3.61M4.04M
Operating Income-30.44M-39.31M-55.27M-38.59M-14.34M-397.80K-419.22K
Other Expenses / Income-8.37M-15.27M-24.83M-2.07M-5.68M2.13M1.61M
Before Tax Income-38.81M-54.57M-80.11M-40.66M-20.02M1.73M1.19M
Income Tax Expenses16.89M-801.00K-628.00K1.71M-5.68M452.78K201.86K
Net Income-55.70M-53.77M-79.48M-42.37M-20.02M632.24K307.30K
Interest Expenses805.00KN/AN/AN/AN/A300.43K307.45K
Basic Shares Outstanding30.04M28.24M28.78M16.90M15.36M16.90M16.90M
Diluted Shares Outstanding30.04M28.24M28.78M16.90M15.36M16.90M16.90M
EBITDA-20.12M-39.31M-55.27M-36.12M-20.02M1.85M1.28M
EBITDA Margin-874.32%-138.84%-1,919.20%-2,429.25%-496.97%28.05%17.54%
EBIT-38.00M-54.57M-80.11M-40.66M-25.71M1.39M816.61K
EBIT Margin-1,651.54%-192.76%-2,781.49%-2,734.23%-638.07%21.05%11.19%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙